---
figid: PMC4264417__fonc-04-00360-g004
figlink: /pmc/articles/PMC4264417/figure/F4/
number: F4
caption: 'Notch–HER2 crosstalk in HER2+ BC (A). Ju et al. determined an intricate
  form of crosstalk between HER2 and Notch-1 in HER2+ breast cancer. HER2+ breast
  cancer cells exhibit an increase in survivin protein expression concomitantly with
  a decrease in survivin mRNA expression. HER2 promotes activation of the AKT pathway,
  which threonine 308 phosphorylated AKT can inhibit p21-mediated inhibition of cyclin
  dependent kinase-1 (CDK1) dimerization to cyclin B1. Concomitantly, HER2-mediated
  activation of the MAPK pathway enables Erk-mediated CDK1-Cyclin B1 dimerization
  as well as inhibition of ubiquitination and proteasomal degradation of survivin
  by restricting the formation of the X-linked Inhibitor of apoptosis protein-X-linked
  associating factor-1(XIAP-XAF-1) complex. Together, AKT and Erk promote dimerization
  of CDK1 to Cyclin B1, which stabilizes survivin by phosphorylating the threonine
  34 residue (Thr34) of the survivin protein. Increased survivin stabilization causes
  an increase in survivin expression. Survivin mRNA is reduced by Erk-mediated inhibition
  of γ-secretase, which in turn inhibits Notch receptor-mediated transcriptional activation.
  (B) Pradeep et al. established an interesting form of crosstalk between the HER2
  and Notch-3 receptors in HER2+ DCIS. HER2 up-regulates the transcription of the
  Notch pathway components: jagged-1, -2 (Jag-1/2), DLL-1, ADAM17, presenilin-1 (Pres-1),
  as well as Notch-3 and Notch-1 (Notch-3/1) through the MAPK pathway. Increased transcription
  of the Notch pathway components causes Notch-mediated up-regulation of c-Myc, Cyclin
  D1, phosphorylation of Serine-473 of Atk (+P-Ser 473 AKT), and down-regulation of
  the tumor suppressor, PTEN. Combined GSI and trastuzumab (Trast) treatment reduce
  HER2+ DCIS cell survival and invasiveness.'
pmcid: PMC4264417
papertitle: Notch-EGFR/HER2 Bidirectional Crosstalk in Breast Cancer.
reftext: Andrew T. Baker, et al. Front Oncol. 2014;4:360.
pmc_ranked_result_index: '85791'
pathway_score: 0.9403701
filename: fonc-04-00360-g004.jpg
figtitle: Notch–HER2 crosstalk in HER2+ BC (A)
year: '2014'
organisms:
- Mus musculus
- Rattus norvegicus
- Human papillomavirus type 16
- Drosophila melanogaster
- Danio rerio
- Homo sapiens
ndex: 66ede06d-df04-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4264417__fonc-04-00360-g004.html
  '@type': Dataset
  description: 'Notch–HER2 crosstalk in HER2+ BC (A). Ju et al. determined an intricate
    form of crosstalk between HER2 and Notch-1 in HER2+ breast cancer. HER2+ breast
    cancer cells exhibit an increase in survivin protein expression concomitantly
    with a decrease in survivin mRNA expression. HER2 promotes activation of the AKT
    pathway, which threonine 308 phosphorylated AKT can inhibit p21-mediated inhibition
    of cyclin dependent kinase-1 (CDK1) dimerization to cyclin B1. Concomitantly,
    HER2-mediated activation of the MAPK pathway enables Erk-mediated CDK1-Cyclin
    B1 dimerization as well as inhibition of ubiquitination and proteasomal degradation
    of survivin by restricting the formation of the X-linked Inhibitor of apoptosis
    protein-X-linked associating factor-1(XIAP-XAF-1) complex. Together, AKT and Erk
    promote dimerization of CDK1 to Cyclin B1, which stabilizes survivin by phosphorylating
    the threonine 34 residue (Thr34) of the survivin protein. Increased survivin stabilization
    causes an increase in survivin expression. Survivin mRNA is reduced by Erk-mediated
    inhibition of γ-secretase, which in turn inhibits Notch receptor-mediated transcriptional
    activation. (B) Pradeep et al. established an interesting form of crosstalk between
    the HER2 and Notch-3 receptors in HER2+ DCIS. HER2 up-regulates the transcription
    of the Notch pathway components: jagged-1, -2 (Jag-1/2), DLL-1, ADAM17, presenilin-1
    (Pres-1), as well as Notch-3 and Notch-1 (Notch-3/1) through the MAPK pathway.
    Increased transcription of the Notch pathway components causes Notch-mediated
    up-regulation of c-Myc, Cyclin D1, phosphorylation of Serine-473 of Atk (+P-Ser
    473 AKT), and down-regulation of the tumor suppressor, PTEN. Combined GSI and
    trastuzumab (Trast) treatment reduce HER2+ DCIS cell survival and invasiveness.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3R5
  - THRA
  - PIK3R4
  - PIK3R6
  - BRAF
  - HRAS
  - PIK3CD
  - BIRC5
  - MAPK10
  - MAPK13
  - NRAS
  - TYRP1
  - PIK3CG
  - PIK3R3
  - TYR
  - RAF1
  - MAPK3
  - NOTCH3
  - ARAF
  - MAPK11
  - MAPK9
  - AKT1
  - AKT2
  - THRB
  - PIK3CA
  - PIK3CB
  - XIAP
  - ERBB2
  - HES1
  - MAP2K2
  - MAPK14
  - KRAS
  - AKT3
  - MAP2K5
  - MAP2K6
  - MAPK1
  - NOTCH2
  - MAP2K1
  - MAP2K7
  - MAP2K4
  - MAP2K3
  - HRG
  - MAPK8
  - NOTCH1
  - EGF
  - MAPK12
  - RBPJ
  - ERBB3
  - NOTCH4
  - Ser
  - Thr
  - Tyr
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Melanoma
  - Noonan syndrome
genes:
- word: PI3K]
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: Thr
  symbol: THR
  source: bioentities_symbol
  hgnc_symbol: THRA
  entrez: '7067'
- word: PI3K]
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K]
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: Raf/MAPKKK
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: PI3K]
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: Survivin
  symbol: survivin
  source: hgnc_alias_symbol
  hgnc_symbol: BIRC5
  entrez: '332'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: TyrP
  symbol: TYRP
  source: hgnc_prev_symbol
  hgnc_symbol: TYRP1
  entrez: '7306'
- word: PI3K]
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K]
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: Tyr
  symbol: TYR
  source: hgnc_symbol
  hgnc_symbol: TYR
  entrez: '7299'
- word: Raf/MAPKKK
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: +Notch
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH3
  entrez: '4854'
- word: Raf/MAPKKK
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: /Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: /Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Thr
  symbol: THR
  source: bioentities_symbol
  hgnc_symbol: THRB
  entrez: '7068'
- word: PI3K]
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K]
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: Erk1/2/MAPK
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: XIAP
  symbol: XIAP
  source: hgnc_symbol
  hgnc_symbol: XIAP
  entrez: '331'
- word: HER2
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: HES-1
  symbol: HES-1
  source: hgnc_alias_symbol
  hgnc_symbol: HES1
  entrez: '3280'
- word: Mek
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: /Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Notch-3
  symbol: NOTCH3
  source: hgnc_symbol
  hgnc_symbol: NOTCH3
  entrez: '4854'
- word: MAPKK
  symbol: MAPKK
  source: bioentities_symbol
  hgnc_symbol: MAP2K5
  entrez: '5607'
- word: MAPKK
  symbol: MAPKK
  source: bioentities_symbol
  hgnc_symbol: MAP2K6
  entrez: '5608'
- word: Erk
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Erk
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: +Notch
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH2
  entrez: '4853'
- word: Mek
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MAPKK
  symbol: MAPKK
  source: bioentities_symbol
  hgnc_symbol: MAP2K7
  entrez: '5609'
- word: MAPKK
  symbol: MAPKK
  source: bioentities_symbol
  hgnc_symbol: MAP2K4
  entrez: '6416'
- word: MAPKK
  symbol: MAPKK
  source: bioentities_symbol
  hgnc_symbol: MAP2K3
  entrez: '5606'
- word: EGF/Hrg
  symbol: HRG
  source: hgnc_symbol
  hgnc_symbol: HRG
  entrez: '3273'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: Notch-1
  symbol: NOTCH1
  source: hgnc_symbol
  hgnc_symbol: NOTCH1
  entrez: '4851'
- word: EGF/Hrg
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: CBF-1
  symbol: CBF1
  source: hgnc_alias_symbol
  hgnc_symbol: RBPJ
  entrez: '3516'
- word: +Notch
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH1
  entrez: '4851'
- word: HER1/3
  symbol: HER3
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB3
  entrez: '2065'
- word: +Notch
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH4
  entrez: '4855'
chemicals:
- word: Ser
  source: MESH
  identifier: D012694
- word: Thr
  source: MESH
  identifier: D013912
- word: Tyr
  source: MESH
  identifier: D014443
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Melanoma
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC4264417__F4
redirect_from: /figures/PMC4264417__F4
figtype: Figure
---
